|
Volumn 2, Issue 1, 2002, Pages 1-9
|
Alzheimer's disease: targets for drug development.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMYLOID BETA PROTEIN;
ALZHEIMER DISEASE;
ANIMAL;
CLINICAL PHARMACOLOGY;
DRUG EFFECT;
HUMAN;
INFLAMMATION;
METABOLISM;
NERVE CELL;
PATHOLOGY;
REVIEW;
ALZHEIMER DISEASE;
AMYLOID BETA-PROTEIN;
ANIMALS;
HUMANS;
INFLAMMATION;
NEURONS;
PHARMACOLOGY, CLINICAL;
|
EID: 0036481246
PISSN: 13895575
EISSN: None
Source Type: Journal
DOI: 10.2174/1389557023406593 Document Type: Review |
Times cited : (13)
|
References (130)
|